ANIK EPS Estimates
Anika Therapeutics, Inc.
$20.69
+$0.44(+2.17%)
50
Overall
40
Value
63
Tech
47
Quality
Market Cap
$276.89M
Volume
84.76K
52W Range
$8.67 - $22.88
Target Price
$23.00
ANIK EPS estimates: the consensus estimate for Anika Therapeutics, Inc.'s current fiscal year is $0.14 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ANIK EPS Estimates
- EPS estimate, current quarter
- $0.27
- EPS estimate, next quarter
- $0.04
- EPS estimate, current year
- $0.14
- EPS estimate, next year
- $0.29
- EPS growth, 3-year
- +9.34%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.76 |
| 2024 | $-3.83 |
| 2023 | $-5.64 |
| 2022 | $-1.02 |
| 2021 | $0.29 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ANIK | $20.69 | +2.2% | 84.76K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Anika Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW